01 1Eli Lilly Kinsale Limited
01 1Imlunestrant
01 1U.S.A
NDC Package Code : 63419-0264
Start Marketing Date : 2024-08-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
11
PharmaCompass offers a list of Imlunestrant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Imlunestrant manufacturer or Imlunestrant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Imlunestrant manufacturer or Imlunestrant supplier.
PharmaCompass also assists you with knowing the Imlunestrant API Price utilized in the formulation of products. Imlunestrant API Price is not always fixed or binding as the Imlunestrant Price is obtained through a variety of data sources. The Imlunestrant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Imlunestrant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imlunestrant, including repackagers and relabelers. The FDA regulates Imlunestrant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imlunestrant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Imlunestrant supplier is an individual or a company that provides Imlunestrant active pharmaceutical ingredient (API) or Imlunestrant finished formulations upon request. The Imlunestrant suppliers may include Imlunestrant API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Imlunestrant as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Imlunestrant API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Imlunestrant as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Imlunestrant and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Imlunestrant NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Imlunestrant suppliers with NDC on PharmaCompass.
We have 1 companies offering Imlunestrant
Get in contact with the supplier of your choice:
